Dan Chen
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- RNA modifications and cancer
- RNA Research and Splicing
- Ubiquitin and proteasome pathways
- RNA and protein synthesis mechanisms
- Protein Degradation and Inhibitors
Papers in
-
- Ferroptosis and cancer prognosis 6
- Lung Cancer Treatments and Mutations 4
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Oncology 17
- Cancer Immunotherapy and Biomarkers 4
- Pancreatic and Hepatic Oncology Research 4
- Co-authors
- Yang Wang (5 shared papers)Jinyao Zhao (4 shared papers)Quan Yang (3 shared papers)Jing Liu (1 shared paper)Yijia Li (1 shared paper)Yi Hu (1 shared paper)Yangzhe Wu (1 shared paper)Shujuan Shao (1 shared paper)
- Journals
- Frontiers in Oncology (3 papers)Cancer Medicine (3 papers)Frontiers in Immunology (3 papers)International Immunopharmacology (2 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Dan Chen
76 papers receiving 1.6k citations
Dan Chen's Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 267
- Molecular Biology 811
- Immunology 200
- Oncology 208
- Pulmonary and Respiratory Medicine 229
Countries citing papers authored by Dan Chen
This map shows the geographic impact of Dan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Chen more than expected).
Fields of papers citing papers by Dan Chen
This network shows the impact of papers produced by Dan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Chen. The network helps show where Dan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | E3 ubiquitin ligases: styles, structures and functions Hit paper breakdown → | 2021 | 254 |
| 2 | Programmed Cell Death Tunes Tumor Immunity Hit paper breakdown → | 2022 | 243 |
| 3 | 2014 | 174 | |
| 4 | 2013 | 131 | |
| 5 | 2016 | 76 | |
| 6 | 2019 | 71 | |
| 7 | 2020 | 35 | |
| 8 | 2020 | 34 | |
| 9 | 2012 | 33 | |
| 10 | 2020 | 32 | |
| 11 | 2023 | 31 | |
| 12 | 2021 | 30 | |
| 13 | 2018 | 28 | |
| 14 | 2018 | 27 | |
| 15 | 2021 | 24 | |
| 16 | 2022 | 20 | |
| 17 | 2014 | 18 | |
| 18 | 2017 | 18 | |
| 19 | 2019 | 18 | |
| 20 | 2015 | 17 |
About Dan Chen
Dan Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Immunology, having authored 77 papers that have together received 1.6k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Lung Cancer Treatments and Mutations (4 papers), RNA Research and Splicing (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (267 citations), Molecular Biology (811 citations), Immunology (200 citations), Oncology (208 citations) and Pulmonary and Respiratory Medicine (229 citations). Dan Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yang Wang, Jinyao Zhao, Quan Yang, Jing Liu, Yijia Li, Yi Hu, Yangzhe Wu, Shujuan Shao, Haili Qian and Yi‐Hsuan Tsai. Their work appears in journals such as Frontiers in Oncology, Cancer Medicine, Frontiers in Immunology, International Immunopharmacology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.